Antibiotic Resistant Articles & Analysis

Our CRP specialists presented the new HORIBA Medical CRP range at the West Medica Africa exhibition, which was held at the Eko Convention Centre in Lagos (Nigeria), from October 12th to 14th, 2015. Our workshop on antibiotic resistance was a great success! For more information on this event, please click ...

By HORIBA Europe GmbH

EFSA’s Panel on Biological Hazards (BIOHAZ) has adopted an opinion on the role of food consumption and processing in human exposure to antimicrobial resistant (AMR) bacteria, an emerging biological hazard caused in part by the use of antimicrobial agents throughout the food chain, from the farm to the fork. The opinion, “Foodborne antimicrobial resistance as a biological hazard”, says that the ...

By The European Food Safety Authority (EFSA)

Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat superbug infections and combat antibiotic resistance, today announced that it has been awarded an additional $9.6 million from the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and ...

By Selux Diagnostics, Inc.

ID Genomics, SPC today announced the completion of its first Pre-Submission meeting with the Food and Drug Administration for the CLoNeT E. coli Assay for Urinary Tract Infections (UTIs). “We continue to make great strides in our development plans for the CLoNeT E. coli Assay,” said Linda Zuckerman, Ph.D., President and CEO. “This unique product will be able to detect the ...

By ID Genomics Inc.

In response to a long awaited report and new executive actions to combat antibiotic resistance announced today by the President’s Council of Advisors on Science and Technology (PCAST), Mae Wu, health attorney at the Natural Resources Defense Council (NRDC), issued the following statement: “Today’s report from the President’s science advisors underscores the crisis ...

By Natural Resources Defense Council

In an oral presentation within the track “AMR & Bacterial Vaccines”, chaired by Dr Jan Poolman (Bacterial Vaccine Discovery and Early Development, Janssen), Dr. Infante showed how Vaxdyn’s technology can deliver endotoxin-free inactivated whole cell vaccines presenting outer-membrane proteins of different bacteria in the surface, therefore raising immunity against ...

By Vaxdyn, S. L.

More than two months after declaring the outbreak appeared to be over, the Centers for Disease Control and Prevention (CDC) has reported an additional 43 people sickened by strains of Salmonella linked to Foster Farms chicken – more than 500 people have reportedly been infected in total. Sixty percent of the tested Salmonella taken from outbreak patients has been resistant to at least one ...

By Natural Resources Defense Council

The rise of antibiotic-resistant bacteria has driven renewed interest in alternative treatments, including phage therapy. A recent study by Yang, F., et al (2024) explores the potential of bacteriophage therapy for treating multi-drug resistant Mycobacterium tuberculosis (Mtb) infections using humanized mouse models. This study highlights the efficacy of phage DS6A in reducing Mtb load ...

By SCIREQ - an emka TECHNOLOGIES Company

Today, Seattle-based ID Genomics, Inc.was awarded a grant from the Longitude Prize Discovery Awards, a seed funding program to help teams competing to win the prestigious Longitude Prize. Run by innovation foundation Nesta and supported by Innovate UK as funding partner, the Longitude Prize is a £10 million prize fund to create a cost-effective, rapid and easy-to-use diagnostic test for ...

By ID Genomics Inc.

Environmental Science & Technology Municipal solid waste is trash — such as plastic, food scraps and lawn clippings — that goes into garbage bins and doesn’t get recycled. Most of this waste is buried in landfills or is incinerated. Now, researchers reporting in ACS’ Environmental Science & Technology have shown that when disposed of in this way, municipal ...

By American Chemical Society (ACS)

Profacgen, a leading provider of custom biotechnology services, is pleased to announce significant updates to its Antimicrobial Peptides (AMPs) Services, enhancing its capabilities to support the growing demand for alternative therapies in the fight against drug-resistant pathogens. As antibiotic resistance continues to pose a global health threat, Profacgen is expanding its services to assist ...

By Profacgen

While much of the media’s attention has been focused on the novel coronavirus that spread across the globe this year, SARS-CoV-2 is not the only emerging threat. Just before reports of the initial outbreak of COVID-19 last year, the Centers for Disease Control and Prevention (CDC) published an update to the agency’s first Antibiotic Resistance Threats in the United States (AR Threats ...

By Cochrane & Associates, LLC

Inflammatix, a pioneering molecular diagnostics company, announced today a contract extension of $12.1 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response. The funding is part of a BARDA contract worth up to $72 million if all options are ...

By Inflammatix, Inc.

Antimicrobial resistance threatens the very core of human healthcare. ID Genomics’ Social Purpose is simple: to limit bacterial resistance and preserve antibiotics for the good of mankind. We believe that antimicrobial resistance connects every human on the planet and that everyone has a right to be protected from this threat. While our core business focuses on developing diagnostics to ...

By ID Genomics Inc.

MicrobioSeq is the microbial genomics division on behalf of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a renowned reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. The product manager is pleased to announce the launch of the Plasmid Identification service, thus helping researchers to efficiently ...

By CD Genomics

U.S. health regulators have known since at least 2009 that the medical devices at the center of the "superbug" outbreak at UCLA can transmit lethal infections but have not recommended any new safety requirements, a lapse that threatens patient safety, experts in hospital-acquired infections said. The latest outbreak involving the reusable devices called duodenoscopes, which are inserted down the ...

By Hunan Vathin Medical Instrument Co., Ltd.

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics MicrobioSeq is committed to delivering comprehensive microbial solutions to human health, agriculture, the environment, and industry by characterizing microbiomes and leveraging microorganisms. The company has recently announced the launch of PCR-based microbial antibiotic resistance ...

By CD Genomics

Chickens farmed for meat and eggs in India’s Punjab state harbour high levels of antibiotic-resistant bacteria, says a new Indo-US study. “Misuse of antibiotics in animal farms endangers all of us because it multiplies drug resistance in the environment,” says Ramanan Laxminarayan, director of the Washington-based Center for Disease Dynamics, Economics and Policy, and who ...

By SciDev.Net

The Food and Drug Administration (FDA) quietly allowed 30 potentially harmful antibiotics, including 18 rated as "high risk," to remain on the market as additives in farm animal feed and water – despite an internal review that raised significant red flags, according to agency records obtained by the Natural Resources Defense Council (NRDC). The data show the use of these drugs in livestock ...

By Natural Resources Defense Council

Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced it has raised $50 million in Series C financing to support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform. "This Series C funding allows us to build out our ...

By Selux Diagnostics, Inc.